Charles Schwab’s Signify Health, Inc. SGFY Stock Holding History

Charles Schwab’s Portfolio SGFY Stock Details SGFY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-396,556	Closed	-$11.4M	–	3608
2022 Q4	$11.4M	Buy	396,556 +11,430	+3%	+$330K	﹤0.01%	1791
2022 Q3	$11.2M	Buy	385,126 +255,748	+198%	+$5.89M	﹤0.01%	1773
2022 Q2	$1.79M	Sell	129,378 -187	-0.1%	-$2.63K	﹤0.01%	2603
2022 Q1	$2.35M	Buy	129,565 +7,034	+6%	+$101K	﹤0.01%	2592
2021 Q4	$1.74M	Buy	122,531 +2,726	+2%	+$42.2K	﹤0.01%	2741
2021 Q3	$2.14M	Sell	119,805 -45,031	-27%	-$1.16M	﹤0.01%	2690
2021 Q2	$5.02M	Buy	164,836 +2,697	+2%	+$74.1K	﹤0.01%	2356
2021 Q1	$4.75M	Buy	+162,139	New	+$5.02M	﹤0.01%	2329

Other funds holding SGFY

BHCM

Brevan Howard Capital Management St. Helier, Jersey $11.3B AUM 35.84% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return

FCA

FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return

Charles Schwab's SGFY Position: Q1 2023 in Review

Charles Schwab sold out of Signify Health, Inc. (SGFY) in Q1 2023, closing a stake of 396,556 shares — an estimated $11.4M sold.

Charles Schwab first reported a position in SGFY in Q1 2021 and held it in 8 quarters. The position peaked at $11.4M in Q4 2022. 5 funds tracked by Wall St. Rank hold SGFY as of Q1 2023.

Charles Schwab reported no remaining Signify Health, Inc. position as of Q1 2023 after selling out during the quarter.
Charles Schwab sold 396,556 Signify Health, Inc. shares in Q1 2023, an estimated $11.4M.
Charles Schwab first reported a position in Signify Health, Inc. in Q1 2021 and held it in 8 quarters.
Charles Schwab's Signify Health, Inc. position peaked at $11.4M in Q4 2022.
5 funds tracked by Wall St. Rank held Signify Health, Inc. as of Q1 2023.

Based on Charles Schwab's 13F filing for Q1 2023, filed 12 May 2023.